PPA2 and cancer: Here, we demonstrate that SCFI can be used to evaluate the viability of human cancer cells, using several different cell lines (PC3, Caco-2, Calu-3 and A549) and two different treatments known to reduce viability in the long term (staurosporine and paclitaxel).